logo

For the Inventor, By the Inventor

le Pecq, France

Adrian Newman-Tancredi

This inventor holds 11 USPTO granted patents. Top assignee: Adir Et Compagnie. Active years: 1997-2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Adrian Newman-Tancredi. Retrieved from https://idiyas.com/inventor/adrian-newman-tancredi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 11

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 4

Forward Citations = 56(Granted Patents)


Company Filing History:

goldMedal11 out of 368 
 
Adir Et Compagnie
 patents

Years Active: 1997-2001

Loading Chart...
11 patents (USPTO):Explore Patents
1. 6172097 - Spiro imidazoline compounds (2001-01-09),
2. 6153625 - Indan-1-ol compounds (2000-11-28),
3. 6127396 - Imidazoline compounds (2000-10-03),
4. 6107345 - Benzocyclobutane compounds (2000-08-22),
5. 6060487 - Indanol compounds (2000-05-09),
6. 5958927 - Indanol compounds (1999-09-28),
7. 5919784 - Heterocyclic aminomethyl compounds (1999-07-06),
8. 5753662 - Piperazine compounds (1998-05-19),
9. 5723484 - Benzopyran compounds as 5-HT.sub.2C receptor antagonists (1998-03-03),
10. 5684020 - Piperazine, piperidine and 1,2,5,6-tetrahydropyridine (1997-11-04),
11. 5663191 - Benzopyran compounds as 5HT.sub.2C receptor antagonists (1997-09-02),

Title: Inventor Adrian Newman-Tancredi: Pioneering Innovations in Le Pecq, FR

Introduction: Adrian Newman-Tancredi is a renowned inventor based in Le Pecq, France, known for his groundbreaking contributions to the field of pharmaceuticals and chemistry.

Latest Patents: Adrian Newman-Tancredi holds several patents related to novel drug compounds and therapeutic treatments, showcasing his commitment to advancing healthcare through innovation.

Career Highlights: With a distinguished career spanning over two decades, Adrian Newman-Tancredi has worked with leading research institutions and pharmaceutical companies, playing a pivotal role in the development of cutting-edge medications.

Collaborations: Throughout his career, Adrian Newman-Tancredi has collaborated with top scientists, researchers, and industry experts, fostering a culture of innovation and excellence in the projects he undertakes.

Conclusion: Adrian Newman-Tancredi's passion for innovation and his relentless pursuit of scientific excellence continue to inspire the next generation of inventors and researchers in the field of pharmaceuticals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…